研究実績の概要 |
Immunosuppression could hinder the induction of cytotoxic T lymphocytes in the tumor cells. Modulation of the immunosuppressive tumor microenvironment is essential for enhancing the anti-tumor efficacy of immune checkpoint blockers. In this study, we determined that the inhibition of vascular adhesion protein 1 using the specific inhibitor U-V296 could reduce the size of tumors, induce anti-tumor T-cells, and synergize with immune checkpoint blockers in an immune dependent manner. These responses can partly be attributed to a reduction in the levels of the pleiotropic signaling molecule H2O2 and the downstream signaling events associated with it, which principally involve reduction in the expressions of IL-4 and other genes related to the Th2/M2-phenotype, angiogenesis, and fibrosis.
|
今後の研究の推進方策 |
We showed that reduction of H2O2 is one of the key mechanisms that cause the improvement of the observed anti-tumor response. To dissect more, we would like to stained the mRNA of various Th1 and Th2 cytokines, other mediators (IFN-g, IL-2, IL-4, IL-13, TGF-β) by RNAScope technology in tumor microenvironment. We will analyze the expression of genes and proteins involved in angiogenesis (Pecam1) and fibrosis (Acta2, Loxl2, a-Sma), transcription factors (Gata3, Irf4 etc) responsible for Th2 or TAMs polarization by qPCR, Western blot and Immunohistochemistry. We also would like to analyze the transcriptome data from our own laboratory and TCGA database to see whether our observed phenomena also exist in human cancers.
|